You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

TICLID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ticlid patents expire, and what generic alternatives are available?

Ticlid is a drug marketed by Roche Palo and is included in one NDA.

The generic ingredient in TICLID is ticlopidine hydrochloride. There are nine drug master file entries for this compound. Additional details are available on the ticlopidine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ticlid

A generic version of TICLID was approved as ticlopidine hydrochloride by APOTEX on July 1st, 1999.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TICLID?
  • What are the global sales for TICLID?
  • What is Average Wholesale Price for TICLID?
Summary for TICLID
Drug patent expirations by year for TICLID
Recent Clinical Trials for TICLID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Dammam UniversityPhase 4
King Fahad Armed Forces HospitalPhase 4
Dammam Central HospitalPhase 4

See all TICLID clinical trials

US Patents and Regulatory Information for TICLID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-001 Mar 24, 1993 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-002 Oct 31, 1991 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TICLID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-002 Oct 31, 1991 ⤷  Sign Up ⤷  Sign Up
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-001 Mar 24, 1993 ⤷  Sign Up ⤷  Sign Up
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-002 Oct 31, 1991 ⤷  Sign Up ⤷  Sign Up
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-001 Mar 24, 1993 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for TICLID

See the table below for patents covering TICLID around the world.

Country Patent Number Title Estimated Expiration
Portugal 73442 PROCESS FOR PREPARING ACID STABILISED COMPOSITIONS OF THIENO-PYRIDINE DERIVED COMPOUNDS ⤷  Sign Up
Belgium 850023 ⤷  Sign Up
Canada 1042438 PROCEDE DE PREPARATION DE NOUVEAUX DERIVES DE LA PYRIDINE (PROCESS FOR THE PREPARATION OF NEW PYRIDINE DERIVATIVES) ⤷  Sign Up
Denmark 344076 ⤷  Sign Up
Spain 449963 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.